DOCSLIB.ORG

World Health Summit Berlin, Germany October 15–17, 2017

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

S ECCI N E · InnOVATION · POLICIES WORLD HEALTH SUMMIT B ERLIN, GERMANY O CTOBER 15–17, 2017 FACTS WORLD HEALTH SUMMIT 2017 | 3 3 DAYS · 40 SESSIONS · 250 SPEAKERS From October 15–17, the 9th World Health Summit will draw Patronage inter national experts from academia, politics, the private sector, Angela Merkel and civil society to Berlin. Chancellor of the Federal Republic of Germany At the World Health Summit (WHS), more than 1,600 stakeholders François Hollande * and decision-makers from over 80 countries and every field in the President of France healthcare spectrum will work together to find solutions to global Jean-Claude Juncker * health challenges. President of the European Commission The world’s foremost strategic forum for global health, it promotes thought leadership in science and advances global health agendas. Presidents 2017 The World Health Summit was founded in 2009 on the occasion of Hélène Boisjoly the 300th anniversary of Berlin’s Charité Hospital. Université de Montréal Detlev Ganten Charité – Universitätsmedizin Berlin PROGRAM STRUCTURE Participants SUNDAY, OCT 15, 2017 • More than 1,600 decision makers 10:30 from over 80 countries on site 13:00 • More than 3,000 people 15:00 worldwide via online live-stream 17:00 WHS OPENING CEREMONY Results • The M8 Alliance Declaration MONDAY, OCT 16, 2017 • Session Reports 9:00 • Statements and recommendations 11:00 made at the WHS are passed on to 13:00 WHS Startup Track National Academies, Governments, 14:00 and International Organizations 16:00 19:00 WHS Night Regional Meetings WHS Regional Meeting North America TUESDAY, OCT 17, 2017 Montreal, May 2017 9:00 WHS Geneva Meeting 11:00 Geneva, April 2016 14:00 WHS Regional Meeting Asia 16:00 WHS CLOSING CEREMONY Kyoto, April 2015 WHS Regional Meeting Latin America São Paulo, April 2014 Session formats WHS Regional Meeting Asia Keynote Panel Discussion Workshop Singapore, April 2013 * Continuation for 2017 requested WHS TOPICS CENTRAL TOPICS 2017 Health Policy in the G7/G20: Vaccination and Eradicating Disease: The Future of Global Health Governance The Role of Research & Development Healthcare has developed into a key policy issue that When it comes to fighting infectious diseases, vaccines is discussed at both national and international levels. o¡er top economic and social value, and they also In 2017, the G20 will for the first time include a meeting of re present the best means for controlling, eliminating national Health Ministers in a forum set to cover topics like and eradicating dangerous communicable pathogens. health security and Antimicrobial Resistance. The health Inten sified global e¡orts to step up vaccine research governance issues inherent in the Sustainable Develop- and development are therefore a must, especially for ment Goals have underlined how increasing financial and neglected tropical diseases. A central challenge is that political commitments are central to solving global health in some developed countries, where popular perceptions challenges. no longer view infection or epidemics as a serious risk, mindsets will need to change. Global Health Security: New Frontiers in Health Sciences: Policy Responses to Planetary Challenges Remodeling Healthcare If we want to create a world that is more secure from The current borders of the health sciences are being infectious diseases and other threats to health, the global constantly redefined, and the latest data is changing community must enhance its collective capacity for views and implementation of science, technology, resilience, and respond more quickly to crises. To reach engineering, and a huge range of other related fields. those goals, we must first create and nurture policy With that in mind, the innovative methods for develop - synergies between nation-states and international orga- ing knowledge, interventions and technology that nizations, and then move towards improving communica- are restructuring healthcare have to focus on a central tion activities with both public and private stakeholders. tenet – improving the health and treatment of patients. Healthy and Resilient Cities: Big Data for Health Governance: Rethinking Urban Transformation Benefits, Frameworks & Ethics Urban populations face many health risks, among them Data is now a cornerstone of the healthcare industry. pollution, noise, overcrowding, trac, insucient access It documents everything from blood pressure readings to drinking water and sanitary facilities, crime, and infec- and surgical records to insurance claims, immunization tious disease. A major challenge is integrating health into histories, patient demographics and receipts of payment. urban planning, investment and policy decisions – and But even though Big Data can bridge the gap between making it a transformative driver of sustainable develop- healthcare delivery and population health and improve ment at the city level. many health outcomes through enhanced methods of research, the detailed collection of personal information poses ethical, regulatory and technical challenges. GENERAL TOPICS • Basic Biological & Medical Research • Universal Health Coverage • Drugs & Vaccines • Clinical & Patient Research • Translational Science & Medicine • Regulatory Aspects • Specific Diseases & Disorders • Public Health & Prevention • Health Visions, Strategies, Ethics • Diagnostics & Therapy • Lifestyle, Physical Activity, Nutrition • Evolutionary Medicine • Medical Technology & Engineering • Patient Safety • Demographic Change & Healthy Aging • Health Policies & Systems • Healthcare Facilities • Global Health and Development WORLD HEALTH SUMMIT 2017 | 5 WHS 2016 CENTRAL TOPICS Migration and Refugee Health: Women, Empowerment and Health: Infectious Diseases: From Care to Policy Equality and Agency Lessons Learned from Ebola to Zika Technological Innovation for Health: Translational Research: Sustainable Development Goals: Improving Healthcare Delivery Advancing Innovative Treatment Transforming the Health Agenda M8 ALLIANCE DECLARATION “We, the members of the M8 Alliance, call on heads of 2. Right to Health of Refugees and Migrants state and government to invest in people and to ensure The M8 Alliance calls for a welcoming of the outcome of that no one is left behind. Following the discussion the first UN Summit on large movements of refugees and at this year’s World Health Summit, action in five key migrants in 2016 which committed to the safety, dignity, central areas of global health is mandatory”: human rights and fundamental freedoms of all migrants and reinforced the legal frameworks for refugees. 1. Empowerment of Women and Girls 2. Right to Health of Refugees and Migrants 3. Resilience and Global Health Security 3. Resilience and Global Health Security The M8 Alliance calls for a welcoming of the outcome of 4. Antimicrobial Resistance the first UN Summit on large movements of refugees and 5. Investment in Research, Development and migrants in 2016 which committed to the safety, dignity, Health Innovation. human rights and fundamental freedoms of all migrants and reinforced the legal frameworks for refugees. Immense strides were made at the UN General Assembly, the World Health Assembly of the WHO, as well as at 4. Antimicrobial Resistance G7 and G20 meetings to strengthen commitments to the The M8 Alliance calls for an endorsement of the political Sustainable Development Goals and to global health action. declaration on antimicrobial resistance and the WHO The right of all people to Universal Health Coverage has action plan on AMR. In particular we support a significant been forcefully endorsed. But at the same time the plight research and development e¡ort on new antimicrobial of millions of people on the move, the predicament of medicines, vaccines and diagnostics, including innovation refugees and the unacceptable destruction of health models. facilities, clearly showed the limits of humanitarian and global health action in the face of lack of political will to 5. Investment in Research, Development ensure human rights, peace and security. and Health Innovation The M8 Alliance calls for cross-sectoral contribution to 1. Empowerment of Women and Girls developing strategies in translational research, securing The M8 Alliance calls for supporting policies which increase the translation of results from clinical studies into every- women’s control of their life choices and ensure their bodily day clinical practice and health decision making, while integrity. This includes the right of women to modern ensuring that new treatments and research knowledge family planning and safe abortion. actually reach the patients or populations for whom they are intended. The M8 Alliance Declaration is available at www.worldhealthsummit.org MEDIA WORLD HEALTH SUMMIT 2017 | 7 In 2016: • About 400 reports (print, online, TV, radio) on the WHS • Twitter: Trending topic on two consecutive days and more • About 200 accredited media representatives than 18 million impressions • More than 200,000 online visitors from 192 countries • Press releases issued to more than 1,800 German and • More than 3,000 participants via livestream from 1,000 international media contacts October 9–11 • Regular newsletters to more than 19,000 subscribers • Facebook: More than 15,000 people reached during worldwide the Summit Further information: www.worldhealthsummit.org/press-media Polish Healthcare Journal Ogólnopolski System Ochrony Zdrowia News agencies: MEDIA PARTNERS In Zusammenarbeit mit: Polish Healthcare Journal Ogólnopolski System Ochrony Zdrowia WHS NIGHT Right
Recommended publications
  • World Health Summit 2020 Information

    World Health Summit 2020 Information

    SCIENCE · INNOVATION · POLICIES WORLD HEALTH SUMMIT DI G I TA L OCTOBER 25–27, 2020 2 “ Availability and “We cannot face affordability of health gender issues products is key. without including Prioritizing low- and diverse identities.” middle-income coun- EPSY CAMPBELL BAR Vice President, Costa Rica tries when innovations are brought to the “ Berlin has become market is an important “ During our EU- “Support multilateralism, a hotspot for global aspect of how industry Presidency in 2020 support women and health. I’m con- can address this. together with support global consen- vinced that global our trio partners JAYASREE IYER sus. It´s important for health has become Executive Director, Portugal and humanity.” Access to Medicine Foundation the important topic Slo venia, we want MARGRET CHAN connecting medi- to make the President, Boao Forum for Asia WHO Emeritus Director-General cine, universities, European voice the private sector, in global health and NGOs.” heard.” “I don’t think we want HEYO KROEMER JENS SPAHN to live in a world where we CEO, Charité – Minister of Health, finally have cures for all Universitätsmedizin Berlin Germany diseases, but they’re unaffordable.” “ Universal health coverage SOUMYA SWAMINATHAN Chief Scientist, WHO must become a political priority. Universal means “For us to achieve universal health universal. It speaks to all coverage, we need to strengthen primary people having this right, healthcare. Two aspects need to be ad- all people having access dressed: infrastructure, which is failing for to health
  • 2Nd Meeting of the ACP Ministers of Health

    2Nd Meeting of the ACP Ministers of Health

    2nd Meeting of the ACP Ministers of Health Reflecting on Intra-ACP cooperation in Health in the post-2015 Development Agenda Brussels, February 23-26, 2015 Prof. Dr. Charles Yankah Professor of Cardiothoracic & Vascular Surgery Charite, Medical University Berlin, Germany Ambassador, World Health Summit President, African Cultural Institute & Pan-African Society for Cardio-Thoracic Surgery (PASCaTS) Special Professor, Univ. of the Free State, Bloemfontein, South Africa [email protected] How to heal the world? Leadership Transfer of Education, Science knowledge and & Technology know-how Change of Awareness behavior Prevention Preparednes & Early diagnosis quick response to National & global health crisis Universal Health commitments Coverage (WHO) The Global Health Forum G8 Meeting in Heiligendamm, Germany 2007 M8 Alliance 7 Vision: To Harness Academic Excellence to Improve Global Health 8 OUR NETWORK 9 WHS 2015 SUNDAY, OCTOBER 11 – TUESDAY, OCTOBER 13 Patronage* . Angela Merkel (Germany) Academia . François Hollande (France) . Jean-Claude Juncker (European Commission) Private Civil Sector Society Policy Makers *Continuation requested 10 BASIC DATA . 200 speakers, 32 sessions + Berlin Health Week . 1,300 participants on-site + 2,500 via livestream from 90 countries . Whole WHS Network: > 16,000 health protagonists Former Speakers (selection) . José Manuel Barroso, Frank-Walter Steinmeier, John G. N. Seakgosing . Harald zur Hausen, Peter Agre, Aaron Ciechanover . Hasso Plattner, Josef Ackermann, Chris Viehbacher 11 OUR TRACKS 1. Education and Leadership Education is the basis for better health in populations. Scientists will have to become change agents, to improve health outcomes and enhance health equity. 2. Research and Innovation Health research is pivotal to create a supportive environment for sustainable economic growth.
  • October 24–26, 2021 2

    October 24–26, 2021 2

    SCIENCE · INNOVATION · POLICIES WORLD HEALTH SUMMIT BERLIN, GERMANY & DIGITAL OCTOBER 24–26, 2021 2 “No-one is safe from COVID-19; “All countries have signed up to Universal no-one is safe until we are all Health Coverage by 2030. But we cannot safe from it. Even those who wait ten years. We need health systems conquer the virus within their that work, before we face an outbreak own borders remain prisoners of something more contagious than within these borders until it is COVID-19; more deadly; or both.” conquered everywhere.” ANTÓNIO GUTERRES Secretary-General, United Nations FRANK-WALTER STEINMEIER Federal President, Germany “We firmly believe that the “All pulling together—this must rights of women and girls be the hallmark of the European are not negotiable.” Health Union. I believe this can NATALIA KANEM be a test case for true global Executive Director, United Nations Population Fund (UNFPA) health compact. The need for leadership is clear and I believe the European Union must as- sume this responsibility.” “The lesson is clear: a strong health URSULA VON DER LEYEN system is a resilient health system. Health President, European Commission systems and preparedness are not only “Governments of countries an investment in the future, they are the that are doing well during foundation of our response today.” the pandemic have not TEDROS ADHANOM GHEBREYESUS Director-General, World Health Organization (WHO) only shown political leader- ship, but also have listened “If we don’t address the concerns and to scientists and followed fears we will not do ourselves a favor. their recommendations.” In the end, it is about how technology SOUMYA SWAMINATHAN Chief Scientist, World Health can be advanced as well as how Organization (WHO) we can make healthcare more human.” BERND MONTAG President and CEO, Siemens Healthineers AG, Germany “The pandemic has brought to light the “Academic collabo ration is importance of digital technologies and in place and is really a how it can radically bridging partnership.
  • Research Uses of Peptides from the Manning Lab 1980 – 2019

    Research Uses of Peptides from the Manning Lab 1980 – 2019

    Research Uses of Peptides from the Manning Lab 1980 – 2019 Over 3,000 samples have been donated to over 820 investigators (some multiple times) in the U.S. and worldwide for their own independent studies. See listings below. These studies have resulted in over 2,000 publications by these investigators. 1. Professor Roger Acher Laboratoire De Chimie Biologique Faculté des Sciences de l’Université de Paris 96, Boulevard Raspail-Paris V1 FRANCE 2. Eli Y. Adashi, M.D. Obstetrics & Gynecology University of Maryland School of Medicine & Hospital 22 South Greene Street Balitmore, MD 21201 3. Greti Aguilera, M.D. Chief Section on Endocrine Physiology DEB, NICHD, NIH Building 10, Room 10N262 10 Center Drive, MSC 1862 Bethesda, MD 20892-1862 4. Dr. K. Al Barazanji Mechanistic Pharmacology Dept. Vascular Biology SmithKline Beecham Pharmaceuticals The Frythe Welwyn, Hertfordshire, AL6 9AR UNITED KINGDOM 5. H. Elliott Albers, Ph.D. Professor of Biology and Psychology Georgia State University Department of Biology College of Arts and Sciences P.O. Box 4010 Atlanta, GA 30302-4010 6. Saad Al-Damluji, B.Sc., MRCP Lecturer in Endocrinology The Medical College of St. Bartholomew’s Hospital West Smithfield, LONDON, EC1A 7BE ENGLAND 7. Natalie Alexander, Ph.D. Department of Medicine University of Southern California School of Medicine 2025 Zonal Avenue Los Angeles, CA 90033 8. O.F.X. Almeida, Ph.D. Max-Planck-Institut Für Psychiatrie Deutsche Forschungsanstalt Für Psychiatrie Abteilung Neuropharmakologie AM Klopferspitz 18A 8033 Planegg-Martinsried WEST GERMANY 9. Dr. Meenakshi Alreja Associate Professor of Psychiatry and Neurobiology Yale University School of Medicine CMHC 335A, 34 Park Street New Haven, CT 06508 10.
  • Sir Charles Sherrington'sthe Integrative Action of the Nervous System: a Centenary Appreciation

    Sir Charles Sherrington'sthe Integrative Action of the Nervous System: a Centenary Appreciation

    doi:10.1093/brain/awm022 Brain (2007), 130, 887^894 OCCASIONAL PAPER Sir Charles Sherrington’sThe integrative action of the nervous system: a centenary appreciation Robert E. Burke Formerly Chief of the Laboratory of Neural Control, National Institute of Neurological Disorders, National Institutes of Health, Bethesda, MD, USA Present address: P.O. Box 1722, El Prado, NM 87529,USA E-mail: [email protected] In 1906 Sir Charles Sherrington published The Integrative Action of the Nervous System, which was a collection of ten lectures delivered two years before at Yale University in the United States. In this monograph Sherrington summarized two decades of painstaking experimental observations and his incisive interpretation of them. It settled the then-current debate between the ‘‘Reticular Theory’’ versus ‘‘Neuron Doctrine’’ ideas about the fundamental nature of the nervous system in mammals in favor of the latter, and it changed forever the way in which subsequent generations have viewed the organization of the central nervous system. Sherrington’s magnum opus contains basic concepts and even terminology that are now second nature to every student of the subject. This brief article reviews the historical context in which the book was written, summarizes its content, and considers its impact on Neurology and Neuroscience. Keywords: Neuron Doctrine; spinal reflexes; reflex coordination; control of movement; nervous system organization Introduction The first decade of the 20th century saw two momentous The Silliman lectures events for science. The year 1905 was Albert Einstein’s Sherrington’s 1906 monograph, published simultaneously in ‘miraculous year’ during which three of his most celebrated London, New Haven and New York, was based on a series papers in theoretical physics appeared.
  • How “Global” Is “Global Health”? Examining the Geographical Diversity of Global Health Thinkers

    How “Global” Is “Global Health”? Examining the Geographical Diversity of Global Health Thinkers

    How “Global” is “Global Health”? Examining the Geographical Diversity of Global Health Thinkers Tess van der Rijt and Tikki Pang Many health issues are transnational in nature and cannot be contained within national borders. Global health is therefore an area of study and research that should involve the collective opinions and ideas of diverse global health thinkers. This paper poses the question: how “global” is ”global health”? Through an analysis of four different contributors shaping global health, including academics, journals, health institutions and presenters at global health conferences, this paper aims to determine if the development of global health is truly global. The paper concludes that global health is not being shaped by those who are most affected by it; the majority of people influencing and defining global health priorities represent institutions based in the developed world. A number of trends and opportunities are identified and recommendations are made to ameliorate the observed imbalance. BACKGROUND Due to globalization, urbanization, and increasing international travel and trade, global health is more relevant than ever. Health issues are oblivious to sovereign states and their individual health policies; they are transnational and can rapidly affect multiple countries. As stated by WHO Director-General Dr. Margaret Chan: “In our mobile, interdependent and interconnected world, threats arising from emerging and epidemic- prone diseases affect all countries. They reinforce our need for shared responsibility and collective action in the face of universal vulnerability…”1 Global health assistance is a multibillion-dollar industry. Between 1990 and 2011, funding of development assistance for health rose from U.S. $5.82 billion to U.S.
  • World Health Summit

    World Health Summit

    Topical Digest World Health Summit 9-11 October 2016 The World Health Summit is a leading annual conference on global health. Launched in 2009, it brings together stakeholders and decision-makers from across the healthcare spectrum. Participants include representatives from politics, industry, civil society and, in particular, academia (the M8 Alliance of Academic Health Centers, Universities and National Academies – a collaboration between academic institutions committed to improving global health – was founded at the World Health Summit's inaugural meeting). Establishing a sustainable high- level forum and network; helping define the future of medicine, research and healthcare; finding answers to major health challenges; and making global recommendations are among the main goals of the World Health Summit. This year's edition, held on 9-11 October at the German Federal Foreign Office in Berlin, mainly focuses on migration and refugee health; technological innovation for health; women, empowerment and health; and the Sustainable Development Goals. European Commission President Jean-Claude Juncker is one of the high patrons of the World Health Summit. The European Parliament, a strong advocate of a systemic and human rights-grounded approach to health, has a key role in advancing the global health agenda. A new vision for global health Briefing by Marta Latek, September 2016 Agenda 2030 has transformed the global health agenda. The new Sustainable Development Goals (SDGs) – and, more specifically, the third goal to 'encourage healthy lives and promote well-being for all at all ages' (SDG 3) – propose a more comprehensive and horizontal vision for health. SDG 3's nine targets and four means of implementation encompass universal access to treatment of a large number of communicable and non-communicable diseases, as well as their prevention.
  • IHP News 493 : World Health Summit 2018 Confirms Germany As a Global Health Hub

    IHP News 493 : World Health Summit 2018 Confirms Germany As a Global Health Hub

    IHP news 493 : World Health Summit 2018 confirms Germany as a global health hub ( 19 October 2018) The weekly International Health Policies (IHP) newsletter is an initiative of the Health Policy unit at the Institute of Tropical Medicine in Antwerp, Belgium. Dear Colleagues, In this week’s issue, the (10th) World Health Summit and annual Grand Challenges meeting (both in Berlin) feature prominently. In the final run-up to the Astana event next week, it’s also raining special supplements on the 40th anniversary of Alma Ata, among others in BMJ Global Health and the Lancet. On Wednesday, after an IHR Emergency Committee got together on the Ebola virus disease outbreak in the Democratic Republic of the Congo, WHO (again) decided the outbreak is not (yet?) a PHEIC, although the situation remains very worrying (and some would have liked indeed, for this reason, a PHEIC); End Poverty Day was “celebrated” as well as the Club of Rome’s 50th birthday this week, London hosted the International Safeguarding Summit, … and there’s plenty of other news. Enjoy your reading. Kristof Decoster Featured Article A few reflections on the World Health Summit 2018 in Berlin Deepika Saluja (IHP resident & EV 2016) & Kristof Decoster (ITM) Both of us recently attended the World Health Summit (WHS) organized in Berlin from 14-16th October, as some of the “over 2000 delegates and 300 speakers from around 100 countries”. The WHS celebrated its 10th Anniversary this year, among others with the launch of a “Global Action Plan for healthy lives and wellbeing for all” in which 11 key global organisations signed a commitment to unite for collective action towards achieving the health related SDG goals & targets, by working in partnership rather than in silos.
  • Metchnikoff and the Phagocytosis Theory

    Metchnikoff and the Phagocytosis Theory

    PERSPECTIVES TIMELINE Metchnikoff and the phagocytosis theory Alfred I. Tauber Metchnikoff’s phagocytosis theory was less century. Indeed, the clonal selection theory and an explanation of host defence than a the elucidation of the molecular biology of the proposal that might account for establishing immune response count among the great and maintaining organismal ‘harmony’. By advances in biology during our own era5. tracing the phagocyte’s various functions Metchnikoff has been assigned to the wine cel- Figure 1 | Ilya Metchnikoff, at ~45 years of through phylogeny, he recognized that eating lar of history, to be pulled out on occasion and age. This figure is reproduced from REF. 14. the tadpole’s tail and killing bacteria was the celebrated as an old hero. same fundamental process: preserving the However, to cite Metchnikoff only as a con- integrity, and, in some cases, defining the tributor to early immunology distorts his sem- launched him into the turbulent waters of evo- identity of the organism. inal contributions to a much wider domain. lutionary biology. He wrote his dissertation on He recognized that the development and func- the development of invertebrate germ layers, I first encountered the work of Ilya tion of the individual organism required an for which he shared the prestigious van Baer Metchnikoff (1845–1916; FIG. 1) in Paul de understanding of physiology in an evolution- Prize with Alexander Kovalevski. By the age of Kruif’s classic, The Microbe Hunters 1.Who ary context. The crucial precept: the organism 22 years, he was appointed to the position of would not be struck by the description of this was composed of various elements, each vying docent at the new University of Odessa, where, fiery Russian championing his theory of for dominance.
  • World Health Summit 2018 Information

    World Health Summit 2018 Information

    S ECCI N E · InnOVATION · POLICIES WORLD HEALTH SUMMIT B ERLIN, GERMANY O CTOBER 14–16, 2018 “The World Health Summit in Berlin is “ It has a real added also a forum that value in times when is held in high inter­ we know that multi­ national esteem lateral platforms in and is dedicated the world are losing to jointly furthering power.” global health.” J OANNE LIU HMNNER A GRÖHE International President, Federal Minister of Health, Médecins Sans Germany Frontières, Switzerland “ The World Health “ The quality of Summit is one people here, the “ This well­known col­ of the best events quality of panels, laborative network of to meet and interact the quality of academic institutions with all aspects of discussions, the works tirelessly to global healthcare, diversity of every­ achieve its main goal: academia, govern­ body has been to improve the health ment, and pharma.” really amazing.” conditions worldwide.” T HOMAS P. LAUR HRH PRINCESS DINA ADAlbERTO CAmpOS President of SAP Health, MIRED OF JORDAN FERNANDES USA President-Elect, Minister of Health, Portugal Union for International Cancer Control, “No other forum Switzerland draws the relative participants so “ I am very excited systematically into by the increased a common discourse attendance of aimed at mastering the young people future challenges of from Africa.” healthcare provision.” MATSHIDISO REBECCA MOETI St EFAN OELRICH WHO Regional Office Executive Vice President “ The World Health for Africa, Switzerland Head of Diabetes and Cardio- vascular GBU, Sanofi, Germany Summit is truly
  • Emil Von Behring (1854–1917) the German Bacteriologist

    Emil Von Behring (1854–1917) the German Bacteriologist

    Emil von Behring (1854–1917) The German bacteriologist and Nobel Prize winner Emil von Behring ranks among the most important medical scientists. Behring was born in Hansdorff, West Prussia, as the son of a teacher in 1854. He grew up in narrow circumstances among eleven brothers and sisters. His desire to study medicine could only be realized by fulfilling the obligation to work as an military doctor for a longer period of time. Between 1874 and 1878 he studied medicine at the Akademie für das militärärztliche Bildungswesen in Berlin. In 1890, after having published his paper Ueber das Zustandekommen der Diphtherie- Immunität und der Tetanus-Immunität bei Thieren, he captured his scientific breakthrough. While having worked as Robert Koch’s scientific assistant at the Berlin Hygienic Institute he had been able to show – together with his Japanese colleague Shibasaburo Kitasato (1852–1931) – via experimentation on animal that it was possible to neutralize pathogenic germs by giving „antitoxins“. Behring demonstrated that the antitoxic qualities of blood are not seated in cells, but in the cell-free serum. Antitoxins recovered of human convalenscents or laboratorty animals, prove themselves as life-saving when being applied to diseased humans. At last – due to Behring’s discovery of the body’s own immune defence and due to his development of serotherapy against diphtheria and tetanus – a remedy existed which was able to combat via antitoxin those infectious diseases which had already broken out. Having developped a serum therapy against diphtheria and tetanus Behring won the first Nobel Prize in Medicine in 1901. Six years before, in 1895, he had become professor of Hygienics within the Faculty of Medicine at the University of Marburg, a position he would hold for the rest of his life.
  • World Health Summit Berlin, Germany October 09–11, 2016

    World Health Summit Berlin, Germany October 09–11, 2016

    SCIENCE · INNOVATION · POLICIES WORLD HEALTH SUMMIT BERLIN, GERMANY OC TOBER 09–11, 2016 FEDERAL FOREIGN OFFICE | BERLIN I am convinced the “ World Health Summit will add valuable The World Health Summit impetus and wish all “ is an excellent venue for participants interesting expert discussion on the and enlightening days. health topics that move us Hermann Gröhe Federal Minister of Health, Germany” worldwide. We can expect it to deliver valuable input. Angela Merkel Chancellor of the ” Your involvement and Federal Republic of Germany “ your declarations at this World Health Summit will play an important role in informing the international community. François Hollande President of the French Republic ” FACTS WORLD HEALTH SUMMIT 2016 | 3 3 DAYS · 40 SESSIONS · 250 SPEAKERS From October 9–11, the 8th World Health Summit will once Patronage again draw international experts from academia, politics, Angela Merkel Federal Chancellor of Germany the private sector, and civil society to the German Federal François Hollande Foreign Oce in Berlin. President of France Jean-Claude Juncker At the World Health Summit (WHS), more than 1,500 stakeholders and President of the decision-makers from every field in the healthcare spectrum will work European Commission together to find solutions to global health challenges. Presidents 2016 The world’s foremost strategic forum for global health, it promotes thought Antoine Flahault leadership in science and global health agendas. The World Health Summit University of Geneva was founded in 2009 on the occasion